Digital microfluidic chips (DMFBs) consists of droplets of fluid ranging between micro-liter to nano-liter scale which perform biochemical assays on a platform with a set of insulated electrodes and essentially scale down operations that would require an entire lab. Microfluidics applications include in-vitro diagnostics, drug administration, cell analysis, immunoassays, protein crystallizations, and DNA amplification. Microfluidic biochips consist of functional layers such as flow layer with microchannels for transportation of sample, and control layer for transmitting control signals (i.e., hydraulic or pneumatic pressure). Elastomer material such as polydimethylsiloxane (PDMS) is used to manufacture these layers. Commercially available products include Vena Delta Y2 Microfluidic Biochip, LabChip, DropletQuant, and ACIX 100.
Restraints of the Global Microfluidics Market
The high cost involved in R&D of microfluidics technology-based products and limited financial support has posed a great challenge to growth of the global microfluidics market.
Key features of the study:
- This report provides in-depth analysis of the global microfluidics market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
- It profiles leading players in the global microfluidics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Agilent Technologies, PerkinElmer Inc., Thermo Fisher Scientific Inc., Qiagen NV, Bio-Rad Laboratories, Inc., Fluidigm Corporation, Abbott Laboratories, and F. Hoffmann-La Roche Ltd.
- Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
- The global microfluidics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
- Global Microfluidics Market, By Material:
- Polymer
- Polyvinyl Chloride (PVC)
- Non-polyvinyl Chloride
- Glass
- Silicon
- Metal
- Ceramics
- Global Microfluidics Market, By Application:
- Point of care testing
- Clinical Diagnostics
- Drug Delivery
- Analytical Testing
- Genomics
- Proteomics
- Cell based Analysis
- Others
- Global Microfluidics Market, By End User:
- Pharmaceuticals
- In-vitro Diagnostics
- Environmental Research
- Life Science Research
- Clinical Diagnostics
- Global Microfluidics Market, By Geography:
- North America
- By Material
- Polymer
- Polyvinyl Chloride (PVC)
- Non-polyvinyl Chloride
- Glass
- Silicon
- Metal
- Ceramics
- By Application
- Point of care testing
- Clinical Diagnostics
- Drug Delivery
- Analytical Testing
- Genomics
- Proteomics
- Cell based Analysis
- Others
- By End User
- Pharmaceuticals
- In-vitro Diagnostics
- Environmental Research
- Life Science Research
- Clinical Diagnostics
- By Country:
- Europe
- By Material
- Polymer
- Polyvinyl Chloride (PVC)
- Non-polyvinyl Chloride
- Glass
- Silicon
- Metal
- Ceramics
- By Application
- Point of care testing
- Clinical Diagnostics
- Drug Delivery
- Analytical Testing
- Genomics
- Proteomics
- Cell based Analysis
- Others
- By End User
- Pharmaceuticals
- In-vitro Diagnostics
- Environmental Research
- Life Science Research
- Clinical Diagnostics
- By Country:
- K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Material
- Polymer
- Polyvinyl Chloride (PVC)
- Non-polyvinyl Chloride
- Glass
- Silicon
- Metal
- Ceramics
- By Application
- Point of care testing
- Clinical Diagnostics
- Drug Delivery
- Analytical Testing
- Genomics
- Proteomics
- Cell based Analysis
- Others
- By End User
- Pharmaceuticals
- In-vitro Diagnostics
- Environmental Research
- Life Science Research
- Clinical Diagnostics
- By Country:
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- By Material
- Polymer
- Polyvinyl Chloride (PVC)
- Non-polyvinyl Chloride
- Glass
- Silicon
- Metal
- Ceramics
- By Application
- Point of care testing
- Clinical Diagnostics
- Drug Delivery
- Analytical Testing
- Genomics
- Proteomics
- Cell based Analysis
- Others
- By End User
- Pharmaceuticals
- In-vitro Diagnostics
- Environmental Research
- Life Science Research
- Clinical Diagnostics
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East:
- By Material
- Polymer
- Polyvinyl Chloride (PVC)
- Non-polyvinyl Chloride
- Glass
- Silicon
- Metal
- Ceramics
- By Application
- Point of care testing
- Clinical Diagnostics
- Drug Delivery
- Analytical Testing
- Genomics
- Proteomics
- Cell based Analysis
- Others
- By End User
- Pharmaceuticals
- In-vitro Diagnostics
- Environmental Research
- Life Science Research
- Clinical Diagnostics
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Material
- Polymer
- Polyvinyl Chloride (PVC)
- Non-polyvinyl Chloride
- Glass
- Silicon
- Metal
- Ceramics
- By Application
- Point of care testing
- Clinical Diagnostics
- Drug Delivery
- Analytical Testing
- Genomics
- Proteomics
- Cell based Analysis
- Others
- By End User
- Pharmaceuticals
- In-vitro Diagnostics
- Environmental Research
- Life Science Research
- Clinical Diagnostics
- By Country/Region:
- Central Africa
- South Africa
- North Africa
- Company Profiles
- Agilent Technologies *
- Company Overview
- Product Portfolio
- Financial Performance
- Key Strategies
- Recent Developments
- PerkinElmer Inc.
- Thermo Fisher Scientific Inc.
- Qiagen NV
- Bio-Rad Laboratories, Inc.
- Fluidigm Corporation
- Abbott Laboratories
- F. Hoffmann-La Roche Ltd.
“*” marked represents similar segmentation in other categories in the respective section.